Munafa Stock Market Course + Intraday & FNO calls 
Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)
Technical Analysis Report for USA stock AKTX Akari Therapeutics. Dated: 26 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics
Akari Therapeutics Opened at 7.64 and Closed at: 7.63, which is -7.86% of previous session's close. It moved within a range of 7.63 and 8.45
The session was a Bearish session with an average volume of 67800, which is 78.76% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 7.22 and resistance for tomorrow is 8.04
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 7.36, 7.08 resistance for tomorrow's hourly charts is 8.18, 8.72
10 Day SMA for Akari Therapeutics (AKTX) is 8.41 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Akari Therapeutics (AKTX) is 8.6 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Akari Therapeutics (AKTX) is 9.23 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 9.94 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Akari Therapeutics is 6.7 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Akari Therapeutics is at 8.6 and 200 DMA is at 6.7, while 50 DMA and 100 DMA are at 9.23 and 9.94 respectively
Akari Therapeutics (AKTX) moving average of 20 SMA is at 8.6 and 20 EMA is at 8.66
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Mon Oct | 7.63 | 8.6 | 8.66 |
| 23 Fri Oct | 8.23 | 8.71 | 8.77 |
| 22 Thu Oct | 8.10 | 8.79 | 8.83 |
| 21 Wed Oct | 8.76 | 8.89 | 8.91 |
| 20 Tue Oct | 9.29 | 8.93 | 8.93 |
| 19 Mon Oct | 9.89 | 8.97 | 8.89 |
Akari Therapeutics (AKTX) moving average of 50 SMA is at 9.23 and 50 EMA is at 9.04
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Mon Oct | 7.63 | 9.23 | 9.04 |
| 23 Fri Oct | 8.23 | 9.22 | 9.1 |
| 22 Thu Oct | 8.10 | 9.2 | 9.14 |
| 21 Wed Oct | 8.76 | 9.18 | 9.18 |
| 20 Tue Oct | 9.29 | 9.16 | 9.2 |
| 19 Mon Oct | 9.89 | 9.13 | 9.2 |
Akari Therapeutics (AKTX) moving average of 100 SMA is at 9.94 and 100 EMA is at 8.81
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Mon Oct | 7.63 | 9.94 | 8.81 |
| 23 Fri Oct | 8.23 | 10.02 | 8.83 |
| 22 Thu Oct | 8.10 | 10.09 | 8.84 |
| 21 Wed Oct | 8.76 | 10.15 | 8.86 |
| 20 Tue Oct | 9.29 | 10.2 | 8.86 |
| 19 Mon Oct | 9.89 | 10.27 | 8.85 |
Akari Therapeutics (AKTX) moving average of 200 SMA is at 6.7 and 200 EMA is at 7.31
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Mon Oct | 7.63 | 6.7 | 7.31 |
| 23 Fri Oct | 8.23 | 6.67 | 7.31 |
| 22 Thu Oct | 8.10 | 6.63 | 7.3 |
| 21 Wed Oct | 8.76 | 6.59 | 7.29 |
| 20 Tue Oct | 9.29 | 6.54 | 7.28 |
| 19 Mon Oct | 9.89 | 6.5 | 7.26 |
Pfizer Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Pfizer Inc, about 25.23% more returns!
Merck Company has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Merck Company, about 15.69% more returns!
Molina Healthcare has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Molina Healthcare, about 29.77% more returns!
Medtronic Plc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Medtronic Plc, about 30.34% more returns!
Becton Dickinson has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Becton Dickinson, about 29.42% more returns!
Tandem Diabetes has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 35.62% more returns!
Tg Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Tg Therapeutics, about 19.01% more returns!
Rhythm Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 14.98% more returns!
Rigel Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 23.59% more returns!
Insulet Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Insulet Corporation, about 33.86% more returns!
Nucana Plc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 7.45% more returns!
Mannkind Corporation has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Mannkind Corporation, about 18.21% more returns!
Lantheus Holdings has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Lantheus Holdings, about 21.91% more returns!
Henry Schein has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 20.96% more returns!
Eton Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 6.26% more returns!
Dexcom Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 12.19% more returns!
Crispr Therapeutics has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 9.02% more returns!
Ani Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 21.47% more returns!
Amgen Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 26.45% more returns!
Akari Therapeutics Technical analysis of indicators
Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Akari Therapeutics in short term and the sell signal is strong.
Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.59 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AKTX Experts View which covers a lot of information including buying and selling signals
AKTX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
